NCT01471327View on ClinicalTrials.gov

Japanese Phase 1 Study of Mepolizumab

PHASE1CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

August 9, 2011

Primary Completion Date

April 27, 2012

Study Completion Date

April 27, 2012

Conditions

Asthma

Interventions

BIOLOGICAL

SB-240563

10mg, 75mg, 250mg and 750mg IV, single dose on Day 1

OTHER

Placebo

Saline IV, single dose at Day 1

Trial Locations (1)

2031

GSK Investigational Site, Randwick

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY